Tesamorelin is a synthetic peptide analog with a trans-3-hexenoic acid modification (CAS 218949-48-5), molecular weight 5135 Da. It consists of 44 amino acids (parent 44-amino-acid sequence) with enhanced stability. Research examines its activity in pituitary signaling models. Research compound — not for human use.
Size and price note: Tesamorelin is currently listed as a single 10mg research-use vial. Review the batch COA availability and checkout total before ordering.
Compound Specifications
Tesamorelin is a synthetic 44-amino-acid peptide analog derived from a parent 44-amino-acid sequence with a trans-3-hexenoic acid modification at the N-terminus, CAS 218949-48-5. Molecular weight approximately 5136 Da. The hexenoic acid moiety stabilizes the peptide against DPP-IV degradation while maintaining receptor agonist activity. Research compound — not for human use.
Product Details
Compound: Tesamorelin (parent 44-amino-acid sequence) Purity: >99% Form: Lyophilized powder Size: 10mg Testing: View COA (Verified by Janoshik) →
Tesamorelin documentation path
This Tesamorelin listing is organized for compound identity review, batch-documentation checks before researchers compare the catalog record with published literature.
Identity: synthetic 44-amino-acid research peptide analog with trans-3-hexenoic acid modification; CAS 218949-48-5; approximate MW 5,135–5,136 Da. Documentation: review available COA records and the Quality & Testing page for batch-verification standards. Literature context: see the Tesamorelin research page and related Sermorelin / Ipamorelin research pages.
Research use only. This page does not provide dosing, administration, reconstitution, treatment, or human-use guidance.